LRTOMT

Transmembrane O-methyltransferase (TOMT) is a protein encoded by the LRTOMT gene in humans. Located on chromosome 11, mutations in LRTOMT are associated with the DFNB63 form of autosomal recessive nonsyndromic hearing loss.

LRTOMT
Identifiers
AliasesLRTOMT, CFAP111, DFNB63, LRRC51, leucine rich transmembrane and O-methyltransferase domain containing, TOMT, LRRC51-TOMT
External IDsOMIM: 612414; MGI: 3769724; HomoloGene: 19664; GeneCards: LRTOMT; OMA:LRTOMT - orthologs
Orthologs
SpeciesHumanMouse
Entrez

220074

791260

Ensembl

ENSG00000284922

ENSMUSG00000078630

UniProt

Q8WZ04
Q96E66

A1Y9I9

RefSeq (mRNA)

NM_001145308
NM_001145309
NM_001145310

NM_001081679
NM_001282088

RefSeq (protein)

NP_001075148
NP_001269017

Location (UCSC)Chr 11: 72.08 – 72.11 MbChr 7: 101.55 – 101.56 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

LRTOMT is a fusion between the LRRC51 and TOMT genes in humans. The fusion gene contains 10 exons that encode two separate proteins translated from unique and overlapping open reading frames (ORFs). Translation of LRTOMT1, a protein that contains leucine-rich repeats, starts in exon 3 and stops at exon 6. Translation of LRTOMT2, also known as TOMT or COMT2, starts in exon 5 and ends at exon 10. Human TOMT has a predicted methyltransferase domain that is conserved with catechol-o-methyltransferase (COMT) and a single predicted transmembrane alpha helix. Mice and zebrafish have separate genes for Lrrc51 and Tomt.[5]

TOMT is required for cochlear hair cell function and is associated with components of the mechanoelectrical transduction (MET) channel, including TMC1. While the mechanism by which TOMT contributes to MET currents and auditory function is currently unknown, the methyltransferase domain is likely not involved. Mutations in TOMT disrupt the stereocilia localization of MET channel subunits and are thus thought to affect MET currents. These results have also been illustrated in multiple mutations in both mice and zebrafish.[6][7]

Clinical significance

Over 20 variants in TOMT have been shown to cause hearing loss in humans. Populations reported to be most affected by TOMT-related hearing loss include Iranian and Tunisian families.[8]

Identified Variants
VariantIdentified Population
Leu16ProIranian
Ala29Ser (frameshift)Turkish
Thr33His (frameshift)American
Met34IluIranian
Pro36Leu (frameshift)Iranian
Ser45Ser (frameshift)Iranian
Glu40AspIranian
Arg41TrpIranian
Arg52TrpPakistani
Arg54GlnJapanese
Leu60ProMauritanian
Trp65ArgTunisian
Arg70XIranian
Tyr71XIranian
Glu80AspIranian
Arg81GlnTunisian
Phe83LeuCzech
Trp105ArgTunisian
Glu110LysTunisian
Tyr111XIranian
Arg158HisChinese
Ala170Ala (frameshift)Iranian
Ilu188Thr (frameshift)Japanese
Arg219XChinese

While most variations cause prelingual profound sensorineural deafness, one patient with compound heterozygous mutations (Arg52Trp and Arg54Gln) was reported to develop ski-slope hearing loss starting at age 11.[9]

TOMT has also been associated with postmenopausal osteoporosis in rats. Specifically, LRTOMT downregulation after ovariectomy was significantly correlated with decreased bone density and changes in bone microstructure.[10]

References

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.